Vetter’s Clinical Facility Demonstrates Success with Five Client Products Now on the Market
With the increasing drug development for novel therapeutics, a growing number of pharmaceutical and biotech companies are seeking clinical manufacturing partners to help meet the demand for complex fill-and-finish solutions. And, while the stages of early drug development are challenging, Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO) is committed to addressing this challenge by offering comprehensive expert manufacturing services for clinical trials and supporting their customer products' path to commercialization. A testament to this commitment is evidenced by the success of its Skokie facility which has already contributed to bringing five new customer products to market since it began full operations in 2011, with another four expected to launch in the next months.
Both
the US Skokie and European Rankweil sites address customer needs in early-phase
drug development
- Clinical development pipeline is essential to global business strategy
- Vetter Development Service offers comprehensive expertise for in-human trial material
- New facility in Austria expands clinical
manufacturing capacity
Ravensburg,
Germany and Rankweil, Austria, and Skokie, US,
February 01, 2023 – With the increasing
drug development for novel therapeutics, a growing number of pharmaceutical and
biotech companies are seeking clinical manufacturing partners to help meet the
demand for complex fill and finish solutions. And, while the stages of early drug
development are challenging, Vetter, a globally leading Contract
Development and Manufacturing Organization (CDMO) is committed to addressing
this challenge by offering comprehensive expert manufacturing services for clinical trials and supporting their customer
products path to commercialization. A testament to this commitment is evidenced
by the success of its Skokie facility which has already contributed
to bring five new customer products to market
since it began full operations in 2011, with another
four expected
to launch in the next months.
Since the opening of
the site, more than 240 customer audits have been
successfully completed and the facility has performed over 45 media fills without
failure. Currently, Vetter Development Service runs more than 80 projects in
phase I and II clinical development. In the past years, the facility executed over
30 transfers from
its early clinical projects to Germany for further late-stage development. “Our
clinical manufacturing sites are an essential part of Vetter’s commercial business
pipeline. And the Skokie site has demonstrated an impressive track record of
success since its opening twelve years ago. In the last year alone, we have
acquired more than 10 new customers and their promising
molecules,” says Dr. Claus Feussner, Senior Vice President Vetter Development
Service. “Overall, our ongoing investments in clinical filling capabilities are
proof of Vetter’s consistent strategic approach to keeping abreast of the
market and our focus on the important drug development needs of our customers,”
adds Carsten Press, Senior Vice President Key Account Management, Supply Chain
Management and Marketing at Vetter.
Next to Vetter
Development Services US, the CDMO’s newest clinical manufacturing site in
Rankweil, Austria has increased the company’s capacity in the important field
of process development as well as clinical manufacturing of Phase I and II
injectables for customers. Purchased by Vetter in 2020, the facility has received its manufacturing
authorization end of 2021 and successfully completed its first
customer fills beginning of last year. Vetter Development Services Austria acts
as a European counterpart to Skokie, helping to expand the CDMO‘s international
presence and increase capacity. Since its opening, the site’s performance has
proven exceptional with fourteen projects already won and
more in the pipeline.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance